300110SZSE
Hua Ren Pharmaceutical Co., Ltd.
华仁药业
300110
Shenzhen Stock Exchange
35 announcements tracked· Last: July 31, 2026
Key Financials
Revenue¥310.0M
Net Profit¥16.0M
ROE1.87%
Debt Ratio66.79%
Monetary Funds¥185.5M
Receivables¥499.5M
Goodwill¥207.9M
Total Shares1.18bn
Announcements
35 totalCSV
Notes & Comments
Sign in to leave a comment or private note.
No notes or comments yet.